Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

February 28, 2014

Study Completion Date

May 31, 2014

Conditions
HIV Infections
Interventions
DRUG

Etravirine (Intelence)

Etravirine 400 mg (four 100 mg or two 200 mg tablets) taken orally once a day with one pill of Truvada (200 mg of emtricitabine and 300 mg of tenofovir) taken orally once a day

DRUG

Truvada

Etravirine 400 mg (four 100 mg or two 200 mg tablets) taken orally once a day with one pill of Truvada (200 mg of emtricitabine and 300 mg of tenofovir) taken orally once a day

Trial Locations (3)

27157

Wake Forest University Health Sciences, Winston-Salem

28207

Carolinas Medical Center, Charlotte

27599-7215

The University of North Carolina at Chapel Hill, Chapel Hill

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Janssen Pharmaceuticals

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER

NCT00959894 - Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection | Biotech Hunter | Biotech Hunter